BioSpace News Archive

Deals

Resverlogix Announces Warrant Exercise Incentive Program

Resverlogix Corp. announces a warrant exercise incentive program designed to encourage the early exercise of 15,593,428 warrants to purchase common shares of the Company.

November 25, 2019
·
3 min read
Deals

Sonoma Pharmaceuticals Announces Proposed Public Offering of Common Stock

Sonoma Pharmaceuticals, Inc. announced the launch of a “best efforts” public offering of shares of its common stock.

November 25, 2019
·
3 min read
Deals

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering at $20 per share

Fortress Biotech, Inc. announced that it has priced an underwritten public offering of 262,500 shares of its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock at a price of $20 per share, with expected gross proceeds to Fortress of approximately $5.3 million.

November 25, 2019
·
5 min read
Business

HALIX Celebrates Grand Opening of its State-of-the-Art cGMP Facility

Official inauguration ceremony of the new facility for the development and manufacturing of biopharmaceuticals

November 25, 2019
·
4 min read
Major trial backs immunotherapy as standard first-line treatment for head and neck cancer

Pembrolizumab either used alone or in combination with chemotherapy was more effective than a standard cocktail of chemotherapy drugs in a study involving nearly 900 patients.

November 25, 2019
·
6 min read
Policy

Promore Pharma publishes supplementary prospectus in connection with the ongoing rights issue

Promore Pharma AB has prepared a supplementary prospectus to the prospectus regarding the rights issue of approx.

November 25, 2019
·
7 min read
Biotech Bay

Diagenode to Offer Single-Cell ATAC-Seq Services Featuring Bio-Rad’s Droplet Digital Technology

Diagenode, Inc. and Bio-Rad Laboratories, Inc. announced a partnership in which Diagenode will offer Single-Cell ATAC-Seq Services, featuring Bio-Rad’s Droplet Digital technology, to help advance epigenomics research.

November 25, 2019
·
4 min read
Business

FLAMMA CEO given Chinese Citizenship for business efforts in China

Flamma SpA is proud to announce that Mr. Gian Paolo Negrisoli, Flamma CEO, has been granted Honorary Dalian Citizenship for his friendship to China and his contribution in promoting economic exchanges and cooperation through Flamma Honkai.

November 25, 2019
·
2 min read
Deals

Alzheimer’s Research UK welcomes Tory ‘Dementia Moonshot’ funding pledge

Alzheimer’s Research UK welcomes the Conservatives’ pledge to double investment in dementia research as a ‘step in the right direction’.

November 25, 2019
·
3 min read
Drug Development

PharmAbcine’s Olinvacimb, able to manage the first recruitment of patients for phase II clinical trial

Safety and efficacy evaluation will be performed on 36 patients from 3 hospitals located in US and Australia

November 25, 2019
·
7 min read